أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

niche generics limited - fluconazole - solution for infusion - 2 mg/ml

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - fluconazole - solution for infusion - 2 mg/ml

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - posaconazole -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate; perindopril erbumine -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 10688 - catheter, angiography - a separate guide-wire is inserted into the catheter using a y-adaptor with valve, in order to flush out the catheter during the procedure. catheter is inserted percutaneously via a suitable introducer selectively into the circulatory system and advanced towards the zone to be examined and/or treated under angiographic control. angiographic catheters are designed for use in selective or global angiographic examinations and therapeutic embolisations.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

medical specialties australasia pty ltd - 10688 - catheter, angiography - the catheter is introduced percutaneously into the vasculature and is used to deliver contrast media for the purpose of diagnostic angiography. angiographic catheters are for use where angiographic diagnosis is indicated.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

biomed limited - hetastarch 10%{relative} (pentastarch) - solution for injection - 10% w/v - active: hetastarch 10%{relative} (pentastarch) excipient: sodium chloride sodium hydroxide water for injection

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

biomed limited - hetastarch 6%{relative} - solution for injection - 6 % - active: hetastarch 6%{relative} excipient: sodium chloride sodium hydroxide water for injection

إسرائيل - الإنجليزية - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - suspension - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses